Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: A probabilistic cost-effectiveness model and value of information analysis

International Journal of Technology Assessment in Health Care

Volumn 23, Issue 2, 2007, Pages 192-204

  Griebsch, Ingolf ^a   Knowles, Rachel L ^b   Brown, Jacqueline ^a   Bull, Catherine ^c   Wren, Christopher ^d   Dezateux, Carol A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Congenital heart defects; Cost effectiveness; Decision analytic model; Newborn screening; Value of information analysis

Indexed keywords

COST EFFECTIVENESS; DECISION THEORY; DISEASES; ECONOMIC AND SOCIAL EFFECTS; ELECTROCARDIOGRAPHY; INFORMATION ANALYSIS; OXIMETERS;

CONGENITAL HEART DEFECTS; DECISION ANALYTIC MODEL; NEWBORN SCREENING; PULSE OXIMETRY;

MEDICAL IMAGING;

ARTICLE; CLINICAL EXAMINATION; CONGENITAL HEART MALFORMATION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECHOCARDIOGRAPHY; FALSE POSITIVE RESULT; HEALTH CARE POLICY; INTERMETHOD COMPARISON; LIVE BIRTH; NEWBORN SCREENING; PROBABILITY; PULSE OXIMETRY; SCREENING TEST;

COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; OXIMETRY; STATE MEDICINE;

EID: 34247381176     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307070304     Document Type: Article

References (43)

1. Acharya G, Sitras V, Maltau JM, et al. Major congenital heart disease in Northern Norway: Shortcomings of pre- and postnatal diagnosis. Acta Obstet Gynecol Scand. 2004;83:1124-1129.
2. Ainsworth S, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F43-F45.
3. Alberman E. The National Down Syndrome Cytogenetic Register (NDSCR). J Med Screen. 2002;9:97-98.
4. Arlettaz R, Archer N, Wilkinson AR. Natural history of innocent heart murmurs in newborn babies: Controlled echocardiographic study. Arch Dis Child Fetal Neonatal Ed. 1998;78:F166-F170.
5. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26:832-835.
6. Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in the United States: Trends and racial disparities, 1979-1997. Circulation. 2001;103:2376-2381.
7. Bove EL, Bull C, Stark J, et al. Congenital heart disease in the neonate: Results of surgical treatment. Arch Dis Child. 1983;58:137-141.
8. Bricker L, Garcia J, Henderson J, et al. Ultrasound screening in pregnancy: A systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technol Assess. 2000;4:i-193.
9. Briggs AH. Handling uncertainty in economic evaluation. In: Drummond MF, McGuire A, eds. Economic evaluation in health care. Oxford, New York: Oxford University Press; 2001:172-214.
10. Brown KL, Ridout DA, Goldman AP, Hoskote A, Penny DJ. Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med. 2003;31:28-33.
11. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet. 1999;354:1242-1247.
12. Chilcott J, Brennan A, Booth A, Karnon J, Tappenden P. The role of modelling in prioritising and planning clinical trials. Health Technol Assess. 2003;7:1-125.
13. Clancy RR, McGaurn SA, Wernovsky G, et al. Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate. J Thorac Cardiovasc Surg. 2000;119:347-357.
14. Claxton K. The irrelevance of inference:Adecision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18:341-364.
15. Claxton K, Neumann PJ, Araki S, Weinstein MC. Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care. 2001;17:38-55.
16. Claxton K, Cohen JT, Neumann PJ. When is evidence sufficient? Health Aff (Millwood). 2005;24:93-101.
17. Clemen RT, Winkler RL. Combining probability distributions from experts in risk analysis. Risk Anal. 1999;19:187-203.
18. de Wahl GA, Mellander M, Sunnegardh J, Sandberg K, Ostman-Smith I. Screening for duct-dependant congenital heart disease with pulse oximetry: A critical evaluation of strategies to maximize sensitivity. Acta Paediatr. 2005;94:1590-1596.
19. Eurocat Surveillance Data: Table B3 1996-1999. Available at: www.biomedicalweb.biz/eurocat. Accessed 2004.
20. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779-787.
21. Glazener CM, Ramsay CR, Campbell MK, et al. Neonatal examination and screening trial (NEST): A randomised, controlled, switchback trial of alternative policies for low risk infants. BMJ. 1999;318:627-631.
22. Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: A critical review of published costutility studies in child health. Pediatrics. 2005;115:e600-e614.
23. Hall DM. The role of the routine neonatal examination. BMJ. 1999;318:619-620.
24. Hoffman JI, Kaplan S. The incidence of congenital heart disease. [Review] [124 refs]. J Am Coll Cardiol. 2002;39:1890-1900.
25. Hoke TR, Donohue PK, Bawa PK, et al. Oxygen saturation as a screening test for critical congenital heart disease: A preliminary study. Pediatr Cardiol. 2002;23:403-409.
26. Hunink MG, Glasziou PP, Siegel JE, et al. Decision making in health and medicine. Cambridge: Cambridge University Press; 2001.
27. Knowles R, Griebsch I, Dezateux C, et al. Newborn screening for congenital heart defects: A systematic review and cos-teffectiveness analysis. Health Technol Assess. 2005;9:1-168.
28. Koppel RI, Druschel CM, Carter T, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics. 2003;111:451-455.
29. Kwon C. FPM. The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med. 2000;154:714-718.
30. Netten A, Rees T, Harrison G. Unit costs of health and social care 2001. The University of Kent, Canterbury: Personal Social Services Research Unit (PSSRU).
31. Office for National Statistics. Death registrations in England and Wales 2002. Health Stat Q. 2003;18:57-64.
32. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 2003;12:697-702.
33. Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003;142:268-272.
34. Richmond S, Reay G, Abu HM. Routine pulse oximetry in the asymptomatic newborn. Arch Dis Child Fetal Neonatal Ed. 2002;87:F83-F88.
35. Roberts TE. Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group. BMJ. 1998;317:911-915.
36. Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital anomalies from 1950 to 1994: An international perspective. J Epidemiol Community Health. 2000;54:660-666.
37. Sands A, Craig B, Mulholland C, et al. Echocardiographic screening for congenital heart disease: A randomized study. J Perinat Med. 2002;30:307-312.
38. Spiegelhalter DJ, Harris NL, Bull K, Franklin RCG. Empirical evaluation of prior beliefs about frequencies: Methodology and a case study in congenital heart disease. J Am Stat Assoc. 1994;89:435-443.
39. Stinnett AA, Mullahy J. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18:S68-S80.
40. Tilford JM. Cost-effectiveness analysis and emergency medical services for children: Issues and applications. Ambul Pediatr. 2002;2(Suppl):330-336.
41. Tulloh RM, Tansey SP, Parashar K, et al. Echocardiographic screening in neonates undergoing surgery for selected gastrointestinal malformations. Arch Dis Child Fetal Neonatal Ed. 1994;70:F206-F208.
42. Wren C, O'Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart. 2001;85:438-443.
43. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: Implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999;80:F49-F53.